IFP Advisors Inc Buys 3,484 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

IFP Advisors Inc lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 160.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,658 shares of the medical equipment provider's stock after purchasing an additional 3,484 shares during the period. IFP Advisors Inc's holdings in Intuitive Surgical were worth $2,802,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AlphaCore Capital LLC increased its position in Intuitive Surgical by 4.2% in the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock valued at $235,000 after acquiring an additional 18 shares during the period. Accredited Investors Inc. grew its holdings in Intuitive Surgical by 1.9% during the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock valued at $543,000 after buying an additional 19 shares during the last quarter. Second Line Capital LLC grew its holdings in Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock valued at $302,000 after buying an additional 19 shares during the last quarter. Colonial Trust Co SC grew its holdings in Intuitive Surgical by 8.8% during the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock valued at $128,000 after buying an additional 20 shares during the last quarter. Finally, Crown Wealth Group LLC lifted its stake in shares of Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 20 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on the company. Deutsche Bank Aktiengesellschaft cut Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday. BTIG Research lifted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research report on Wednesday. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday. Finally, Royal Bank Of Canada lifted their price target on Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $592.05.

Intuitive Surgical Stock Down 2.8%

Shares of NASDAQ:ISRG traded down $13.81 during midday trading on Thursday, reaching $488.15. 1,470,103 shares of the company were exchanged, compared to its average volume of 1,985,528. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a fifty day simple moving average of $532.65 and a two-hundred day simple moving average of $535.75. The firm has a market cap of $174.96 billion, a PE ratio of 68.08, a P/E/G ratio of 5.42 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.89%. The firm's quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the business posted $1.78 earnings per share. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares of the company's stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director directly owned 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock worth $2,611,577 in the last three months. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.